Fawcett leads a team of communicators who produce targeted, innovative communication for the Rogel Cancer Center’s research and clinical enterprises. Prior to Michigan Medicine, Fawcett was a reporter at the Detroit News and editor for a web-based community for people with disabilities.
A new perspective looks at the built-in bias within the factors that drive physicians’ salaries and makes recommendations for how institutions can close the gap.
In a clinical trial, adding interferon treatment with a bone marrow transplant bolstered outcomes for patients with advanced, high-risk leukemia.
A protein called PIKfyve impacts multiple processes involved in metabolism and cell death; blocking it is key to making immunotherapy work in prostate cancer.
The pandemic has magnified issues of gender equity that permeate medicine. Can it also be the catalyst for real change?
Findings offer clues to why some types of renal cell carcinoma respond to immunotherapy while others do not.
Stopping the interaction between KRAS and the protein AGO2 slowed tumor growth in mouse models.
